rxstat › Shortages › Capmatinib

Capmatinib shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Capmatinib has no current shortage reported in Canada. No active reports are on file.
Products affected
0 / 1
Reports on file
1

Reports by product

Resolved
TABRECTA
150MG · TABLET · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02527391 · ended Jul 14, 2025 · Demand increase for the drug.

What's happening

There are no active shortage reports for Capmatinib.

Recent changes

Common questions

When will Capmatinib be back in stock in Canada?

Capmatinib has no active shortage; supply is normal per Health Canada reports.

Why is Capmatinib in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs

Widespread shortageImatinib7 of 14 reported products affected · est. return Jul 31, 2026Partial shortageDasatinib1 of 14 reported products affectedPartial shortageEverolimus1 of 11 reported products affected · est. return Jul 10, 2026Partial shortageGefitinib1 of 4 reported products affected · est. return Dec 31, 2026Partial shortageSunitinib1 of 9 reported products affected · est. return Jul 15, 2026Shortage anticipatedAfatinib0 of 4 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.